Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2021 Dec 30;149(6):1992–1997.e12. doi: 10.1016/j.jaci.2021.11.027

Table I.

Clinical characteristics of FHS participants

Characteristic (Mean ± SD) All participants (n=6,546) Participants with asthma (n=375) Participants free of asthma (n=6,171)
Age, years 49.6 ± 13.8 49.8 ± 14.3 49.6 ± 13.7
Women, n (%) 3474 (53.1%) 247 (65.9%) 3227 (52.3%)
BMI, kg/m 2 27.4 ± 5.4 28.4 ± 6.1 27.3 ± 5.4
Smoking, pack years 10.7 ± 18.1 12.8 ± 20.9 10.6 ± 17.9
sRAGE, pg/mL 3574.0 ± 1167.7 3391.4 ± 1089.0 3585.1 ± 1171.5

Abbreviations: BMI = Body Mass Index (kg/m2); FHS = Framingham Heart Study; SD = Standard Deviation; sRAGE = Soluble Receptor for Advanced Glycation End-Products